Enter your login e-mail to the account
Search
Search parameters
Search results
- Individual approach choosing appropriate therapy for patient with multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(5/2016, Interdisciplinary consilium ) - Multiple sclerosis and motherhood The article deals with the relationship of multiple
MUDr. Viera Hančinová
(1/2013, Interdisciplinary consilium ) - Sclerosis multiplex – informácie pre prax
doc. MUDr. Eleonóra Klímová, CSc.
(5/2006, Consilium ) - Adherence to the treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc.
(4/2016, Interdisciplinary consilium ) - Poruchy kognitívnych funkcií u pacientov so sclerosis multiplex
doc. MUDr. Eleonóra Klímová, CSc.
(S4/2008, Supplement )
- The impairment of memory functions in patients with multiple sclerosis
PhDr. Ján Grossmann, MUDr. Štefan Sivák, PhD., MUDr. Jozef Michalík, PhD., MUDr. Ema Kantorová, PhD., prof. MUDr. Egon Kurča, PhD.
(1/2017, Review articles ) - Multiple sclerosis – psychoneuroimmunological disease of the central nervous system
doc. MUDr. Eva Havrdová, CSc., MUDr. Eva Krasulová, Mgr. Jana Blahová Dušánková
(3/2009, Review articles ) - MULTIPLE SCLEROSIS AND DEPRESSION
doc. MUDr. Eva Havrdová, CSc., MUDr. Zdena Čechová
(5/2005, Review articles )
- Intrathecal synthesis of specific antiviral antibodies in relapsing-remitting and primary chronic progressive courses of multiple sclerosis
doc. MUDr. Pavel Štourač, Ph.D., MUDr. Jana Bednářová, Ph.D.
(5/2009, Main topic ) - New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - Management of secondary-progressive multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(1/2022, Review articles ) - Experience with shortened ocrelizumab infusion – ENSEMBLE PLUS study
doc. MUDr. Yvonne Benešová, Ph.D.
(1/2022, Review articles ) - Link atrophy and disability in multiple sclerosis
MUDr. Jiří Piťha
(3/2014, Review articles ) - Alemtuzumab treatment in multiple sclerosis: real clinical experience
MUDr. Viktória Halušková, MUDr. Zbyšek Pavelek, PhD., doc. MUDr. Martin Vališ, Ph.D.
(5/2019, Case reports ) - Terapeutický algoritmus u roztroušené sklerózy
doc. MUDr. Eva Havrdová, CSc.
(3/2005, Review articles ) - Central nervous system vasculitis
MUDr. Aleš Tomek, Ph.D., FESO
(6/2015, Main topic ) - Cognitive impairment in multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2015, Review articles ) - Glatiramer acetate: long-term immunomodulatory therapy in multiple sclerosis – safety, efficacy, adherence and persistence assesment
MUDr. Olga Zapletalová
(2/2016, Review articles ) - Anti CD20 multiple sclerosis therapy
Doc. MUDr. Pavel Štourač, Ph.D.
(1/2018, Pharmacotherapy ) - Headache and Multiple Sclerosis
MUDr. Soňa Feketová
(4/2010, Review articles ) - Efficacy and safety of ocrelizumab in multiple sclerosis
MUDr. Radek Ampapa
(5/2017, Review articles ) - Imunomodulační terapie u sclerosis multiplex
MUDr. Pavel Štourač, Ph.D.
(5/2002, Main topic ) - Long‑term effect of siponimod on MRI outcomes in patients with secondary‑progressive multiple sclerosis
MUDr. Simona Halúsková, prof. MUDr. Martin Vališ, Ph.D., FEAN
(4/2022, Review articles ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Woman and multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(6/2014, Main topic ) - Correlation of MхA mRNA expression with NAbs levels in patients with multiple sclerosis
MUDr. Aleš Tomek, MUDr. Eva Meluzínová, MUDr. Václav Maťoška, MUDr. Jana Libertínová, Mgr. Tereza Kumstýřová, Mgr. Miroslav Zajac, Mgr. Zuzana Lacinová
(6/2011, Case reports ) - The individual preferences in choice of suitable MS treatment therapy
MUDr. Marta Vachová
(6/2014, Review articles ) - Fingolimod in clinical practice: case reports
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(6/2014, Case reports ) - Cognitive dysfunction in multiple sclerosis
MUDr. Michal Dufek
(3/2009, Review articles ) - Recent advances in treatment of multiple sclerosis with interferon beta in Czech Republic?
MUDr. Michal Dufek
(1/2011, Review articles ) - Porovnanie bezpečnosti a monitoringu DMD liekov prvej eskalačnej línie – dimetylfumarát, fingolimod, kladribin a okrelizumab
MUDr. Eva Kmeťová
(6/2018, Review articles ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Teriflunomid u mladých žen
MUDr. Petra Praksová, Ph.D.
(6/2018, Pharmacotherapy ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - Ocrelizumab – pharmacoloical profile
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(5/2018, Pharmacotherapy ) - Hepatic impairment during the treatment multiple sclerosis by dimethyl-fumarate
MUDr. Květoslava Aiglová, Ph.D., prof. MUDr. Jiří Ehrmann, CSc.
(5/2018, From the boundary of neurology ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - NEDA-4 concept as a treatment outcome in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(3/2016, Review articles ) - Clinical experience with alemtuzumab
MUDr. Eva Meluzínová, MUDr. Jana Libertínová, MUDr. Petra Lišková
(3/2016, Case reports ) - Dimethyl-fumarate in treating relapsing-remitting multiple sclerosis
MUDr. Eva Meluzínová
(4/2014, Review articles ) - Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective
Prof. MUDr. Tomáš Kozák, Ph.D.
(6/2016, From the boundary of neurology ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Escalation therapy in multiple sclerosis
MUDr. Pavel Ryška, Ph.D., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2016, Case reports ) - Long-term data of multiple sclerosis treatment with ocrelizumab – eficacy, safety and clinical experience
MUDr. Mgr. Matouš Rous, MUDr. Zuzana Rous, Ph.D.
(6/2021, Review articles ) - Treatment of multiple sclerosis in Czech Republic – options and reality
MUDr. Michal Dufek
(1/2014, Review articles ) - ROZTROUŠENÁ SKLERÓZA: ZÁNĚT NEBO NEURODEGENERACE?
doc. MUDr. Eva Havrdová, CSc.
(2/2007, Review articles ) - Adherence to treatment in multiple sclerosis
MUDr. Pavel Hradílek, Ph.D.
(3/2012, Review articles ) - Treatment persistence to ocrelizumab and local experience
MUDr. Simona Halúsková, prof. MUDr. Martin Vališ, Ph.D., FEAN
(3/2021, Review articles ) - Efficacy and safety of ofatumumab in naive MS patients.
MUDr. Martina Martiníková
(5/2023, Informations ) - Súčasné možnosti dlhodobej liečby roztrúsenej sklerózy: výhody a nevýhody perorálnej liečby roztrúsenej sklerózy
MUDr. Zuzana Matejčíková, Ph.D.
(3/2018, Review articles ) - B cells as a target in the treatment of multiple sclerosis
MUDr. Luděk Hochmuth
(3/2017, Review articles ) - Listeria meningitis after administration of alemtuzumab for relapsing-remitting multiple sclerosis
MUDr. Pavel Hradílek, Ph.D., MUDr. Petr Hon
(3/2017, Case reports ) - COVID-19 in patients with multiple sclerosis treated with ofatumumab
MUDr. Eva Recmanová
(2/2023, Review articles ) - Drug induced hepatopathy after fingolimod treatment
MUDr. Magdaléna Hladíková, Ph.D., MUDr. Petra Praksová, Ph.D.
(4/2015, Case reports ) - Alemtuzumab in multiple sclerosis treatment
MUDr. Eva Meluzínová
(4/2015, Pharmacotherapy ) - Ocrelizumab – long-term efficacy and safety in real-world clinical practice in patients with relapsingremitting multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2022, Review articles ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic ) - New treatment options for pediatric patients with multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(3/2019, Review articles ) - Primary progressive multiple sclerosis – diagnosis, clinical aspects and treatment
MUDr. Ladislav Gurčík, PhD.
(5/2011, Review articles ) - Interferon-β biological activity; monitoring of the treatment effect in multiple sclerosis patients in the Czcech republic
MUDr. Eva Meluzínová, MUDr. Václav Maťoška, MUDr. Jana Libertínová, Mgr. Miroslav Zajac
(5/2013, Case reports ) - Teriflunomide in treating relapsing-remitting multiple sclerosis – immunomodulatory mechanisms
doc. MUDr. Vojtěch Thon, Ph.D.
(1/2016, Pharmacotherapy ) - Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis
MUDr. Marek Peterka
(6/2022, Review articles ) - Role of subcutaneous interferon beta-1a in treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa
(4/2021, Review articles ) - PEGylated interferon beta-1a: a novel interferon in treating multiple sclerosis
MUDr. Pavel Hradílek, Ph.D.
(4/2017, Review articles ) - Cesta ke spolehlivé diagnostice roztroušené sklerózy
MUDr. Radomír Taláb, CSc.
(4/2008, Main topic ) - Treatment with the monoclonal antibody alemtuzumab: effect on the manifestation of thyroid disorders
Prof. MUDr. Petr Vlček, CSc., RNDr. Dana Nováková
(4/2017, From the boundary of neurology ) - Léčba relaps-remitentní roztroušené sklerózy mozkomíšní
doc. MUDr. Eva Havrdová, CSc., MUDr. Eva Krasulová
(4/2008, Main topic ) - Léčba progresivní roztroušené sklerózy
MUDr. Ivana Kovářová
(4/2008, Main topic ) - New ways of administering injection drugs in relapsing multiple sclerosis
MUDr. Jiří Piťha
(5/2015, Review articles ) - Clinical experiences in multiple sclerosis patients treated with alemtuzumab
MUDr. Mária Ďurišová, MUDr. Eva Recmanová
(2/2020, Case reports ) - B‑ lymphocyte‑ targeted MS therapy: from theory to a decade of ocrelizumab in practice
MUDr. Dominika Šťastná, Ph.D., MUDr. Jana Seňavová, prof. MUDr. Dana Horáková, Ph.D.
(2/2024, Review articles ) - Clinically isolated syndrome and treatment with glatiramer acetate
MUDr. Radek Ampapa, MUDr. Vladislav Cunder, MUDr. Martin Svárovský
(2/2015, Case reports ) - Correlation between magnetic resonance imaging and clinical disability in multiple sclerosis
prof. MUDr. Zdeněk Seidl, CSc., doc. MUDr. Manuela Vaněčková, Ph.D.
(5/2014, Review articles ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles ) - Assessing quality of life of patients with multiple sclerosis
MUDr. Ema Kantorová, PhD, prof. MUDr. Egon Kurča, PhD.,, MUDr. Jozef Michalik
(4/2012, Review articles ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )
- Cutaneous complications of the 1. line immunomodulators in the Multiple Sclerosis treatment
doc. MUDr. Eleonóra Klímová, CSc., MUDr. Adrián Ryník, MUDr. Monika Daňová, PhDr. Andrea Lengyelová
(1/2013, Interdisciplinary consilium )
- History, diagnosis and experiences of patients with multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(3/2013, Current pharmacotherapy ) - The current therapeutic options for relapsing-remiting form of multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(1/2013, Current pharmacotherapy ) - New therapy options for multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(4/2013, Current pharmacotherapy )
- Chronic cerebrospinal venous insufficiency and its controversial relationship with multiple sclerosis
MUDr. Juraj Maďarič, PhD., MPH, MUDr. Ivan Vulev, PhD., MPH, FCIRSE
(1/2014, Main topic )